Difamilast, a selective phosphodiesterase 4 inhibitor, ointment in paediatric patients with atopic dermatitis: a phase III randomized double‐blind, vehicle‐controlled trial

BACKGROUND: In atopic dermatitis (AD), phosphodiesterase 4 (PDE4) inhibition reduces proinflammatory mediators and cytokines. Difamilast is a new selective PDE4 inhibitor. OBJECTIVES: To demonstrate the superiority of topical difamilast to vehicle in Japanese paediatric patients with AD. METHODS: Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Saeki, H., Baba, N., Ito, K., Yokota, D., Tsubouchi, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298328/
https://www.ncbi.nlm.nih.gov/pubmed/34289086
http://dx.doi.org/10.1111/bjd.20655

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298328/
https://www.ncbi.nlm.nih.gov/pubmed/34289086
http://dx.doi.org/10.1111/bjd.20655

Ejemplares similares